SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,239,000 | -19.1% | 3,364,895 | 0.0% | 2.95% | -0.5% |
| Q1 2022 | $4,004,000 | -65.3% | 3,364,895 | -4.9% | 2.97% | -26.4% |
| Q4 2021 | $11,540,000 | -24.9% | 3,539,895 | +2.9% | 4.03% | -10.8% |
| Q3 2021 | $15,376,000 | -18.0% | 3,439,895 | 0.0% | 4.52% | -2.9% |
| Q2 2021 | $18,747,000 | -20.2% | 3,439,895 | +9.6% | 4.66% | +3.4% |
| Q1 2021 | $23,486,000 | -18.1% | 3,139,895 | +18.8% | 4.50% | -8.3% |
| Q4 2020 | $28,671,000 | – | 2,642,500 | – | 4.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |